Gelteq (GELS) Non-Current Debt (2023 - 2025)
Gelteq's (GELS) quarterly Non-Current Debt came in at $3.3 million in Q4 2025, up 31.89% year-on-year from $2.5 million in Q4 2024, and up 24.38% quarter-over-quarter from $2.7 million in Q2 2025.
Gelteq (GELS) Non-Current Debt (2023 - 2025) Analysis & Trends
Gelteq's Non-Current Debt history runs 3 years deep, the most recent figure standing at $3.3 million for Q4 2025.
- On a quarterly basis, Non-Current Debt rose 31.89% year-over-year to $3.3 million in Q4 2025; TTM through Dec 2025 was $3.3 million, a 31.89% increase from a year earlier, with the FY2025 full-year figure at $2.7 million, up 132.19% from the prior year.
- Non-Current Debt advanced to $3.3 million in Q4 2025 per GELS's latest filing, from $2.7 million in the prior quarter.
- Across five years, Non-Current Debt topped out at $3.3 million in Q4 2025 and bottomed at $1.2 million in Q2 2024.
- The 3-year median for Non-Current Debt is $2.5 million (2024), against an average of $2.3 million.
- Across the five-year window, Non-Current Debt retreated 29.81% in 2024 and soared 132.19% in 2025, its largest moves.
- Year by year, Non-Current Debt stood at $1.7 million in 2023, then soared by 53.71% to $2.5 million in 2024, then soared by 31.89% to $3.3 million in 2025.
- Per Business Quant, the three latest GELS Non-Current Debt figures stand at $3.3 million (Q4 2025), $2.7 million (Q2 2025), and $2.5 million (Q4 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 10.34 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 14.02 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 9.05 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 27.86 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 12.41 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 3.74 Bn |
| 10 | Gelteq | 740.00 | -47,821.64 | - | 3.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.35 Mn |
| Jun 30, 2025 | 2.69 Mn |
| Dec 31, 2024 | 2.54 Mn |
| Jun 30, 2024 | 1.16 Mn |
| Jun 30, 2023 | 1.65 Mn |